Abstract
We describe the current and future objectives of the Women Stroke Association, a nonprofit multidisciplinary organization promoting research awareness on medical, psychological, and social issues concerning women affected by cerebro-cardiovascular disease. In this paper, we deal with only cerebrovascular disease, whereas cardiovascular disorders will be addressed in a future paper. Gender differences in the clinical presentation of cerebrovascular diseases have been repeatedly suggested, and some treatment options may not be as effective and safe in men and women. For many years, women have either been underrepresented or excluded from randomized clinical trials, and the majority of therapeutic research has been carried on predominantly male populations. Furthermore, gender differences have been shown to contribute to different responses to cerebrovascular drugs in women when compared with men, regarding pharmacokinetics, pharmacodynamics, and physiology. In this statement, we discuss main research fields relevant to Women Stroke Association's mission and commitment, highlighting opportunities and critical from the women's health perspective. Future directions and goals of the Women Stroke Association arise from these considerations and represent the association's commitment to combating stroke.
| Original language | English |
|---|---|
| Pages (from-to) | 20-27 |
| Number of pages | 8 |
| Journal | International Journal of Stroke |
| Volume | 9 |
| Issue number | A100 |
| DOIs | |
| Publication status | Published - Oct 1 2014 |
Fingerprint
Keywords
- Epidemiology
- Gender medicine
- Methodology
- Risk factors
- Stroke
- Therapy
ASJC Scopus subject areas
- Neurology
Cite this
Women stroke association statement on stroke. / Pezzella, Francesca Romana; Santalucia, Paola; Vadalà, Rita; Giugni, Elisabetta; Zedde, Maria Luisa; Sessa, Maria; Anticoli, Sabrina; Caso, Valeria.
In: International Journal of Stroke, Vol. 9, No. A100, 01.10.2014, p. 20-27.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Women stroke association statement on stroke
AU - Pezzella, Francesca Romana
AU - Santalucia, Paola
AU - Vadalà, Rita
AU - Giugni, Elisabetta
AU - Zedde, Maria Luisa
AU - Sessa, Maria
AU - Anticoli, Sabrina
AU - Caso, Valeria
PY - 2014/10/1
Y1 - 2014/10/1
N2 - We describe the current and future objectives of the Women Stroke Association, a nonprofit multidisciplinary organization promoting research awareness on medical, psychological, and social issues concerning women affected by cerebro-cardiovascular disease. In this paper, we deal with only cerebrovascular disease, whereas cardiovascular disorders will be addressed in a future paper. Gender differences in the clinical presentation of cerebrovascular diseases have been repeatedly suggested, and some treatment options may not be as effective and safe in men and women. For many years, women have either been underrepresented or excluded from randomized clinical trials, and the majority of therapeutic research has been carried on predominantly male populations. Furthermore, gender differences have been shown to contribute to different responses to cerebrovascular drugs in women when compared with men, regarding pharmacokinetics, pharmacodynamics, and physiology. In this statement, we discuss main research fields relevant to Women Stroke Association's mission and commitment, highlighting opportunities and critical from the women's health perspective. Future directions and goals of the Women Stroke Association arise from these considerations and represent the association's commitment to combating stroke.
AB - We describe the current and future objectives of the Women Stroke Association, a nonprofit multidisciplinary organization promoting research awareness on medical, psychological, and social issues concerning women affected by cerebro-cardiovascular disease. In this paper, we deal with only cerebrovascular disease, whereas cardiovascular disorders will be addressed in a future paper. Gender differences in the clinical presentation of cerebrovascular diseases have been repeatedly suggested, and some treatment options may not be as effective and safe in men and women. For many years, women have either been underrepresented or excluded from randomized clinical trials, and the majority of therapeutic research has been carried on predominantly male populations. Furthermore, gender differences have been shown to contribute to different responses to cerebrovascular drugs in women when compared with men, regarding pharmacokinetics, pharmacodynamics, and physiology. In this statement, we discuss main research fields relevant to Women Stroke Association's mission and commitment, highlighting opportunities and critical from the women's health perspective. Future directions and goals of the Women Stroke Association arise from these considerations and represent the association's commitment to combating stroke.
KW - Epidemiology
KW - Gender medicine
KW - Methodology
KW - Risk factors
KW - Stroke
KW - Therapy
UR - http://www.scopus.com/inward/record.url?scp=84912044032&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84912044032&partnerID=8YFLogxK
U2 - 10.1111/ijs.12110
DO - 10.1111/ijs.12110
M3 - Article
VL - 9
SP - 20
EP - 27
JO - International Journal of Stroke
JF - International Journal of Stroke
SN - 1747-4930
IS - A100
ER -